Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia

被引:52
|
作者
Quintanilla-Martinez, Leticia [1 ,2 ]
Sander, Birgitta [3 ,4 ]
Chan, John K. C. [5 ]
Xerri, Luc [6 ]
Ott, German [7 ,8 ]
Campo, Elias [9 ]
Swerdlow, Steven H. [10 ]
机构
[1] Univ Tubingen, Inst Pathol & Neuropathol, Liebermeisterstr 8, D-72076 Tubingen, Germany
[2] Univ Tubingen Hosp, Ctr Comprehens Canc, Liebermeisterstr 8, D-72076 Tubingen, Germany
[3] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden
[4] Karolinska Univ Hosp Huddinge, Stockholm, Sweden
[5] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[6] Inst J Paoli I Calmettes, Dept Biopathol, F-13009 Marseille, France
[7] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany
[8] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany
[9] Univ Barcelona, Hosp Clin, Barcelona, Spain
[10] Univ Pittsburgh, Sch Med, Dept Pathol, Div Hematopathol, Pittsburgh, PA USA
关键词
Indolent pediatric lymphomas; Pediatric-type follicular lymphoma; Pediatric nodal marginal zone lymphoma; IRF4/MUM1+lymphomas; Waldeyer's ring lymphomas; B-CELL LYMPHOMA; HIGH PROLIFERATION INDEX; NON-HODGKINS-LYMPHOMA; CLINICOPATHOLOGICAL ANALYSIS; TNFRSF14; MUTATIONS; NODULAR LYMPHOMA; CHILDREN; TESTIS; EXPRESSION; CHILDHOOD;
D O I
10.1007/s00428-015-1855-z
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Indolent lymphomas in the pediatric population were discussed during the 2014 European Association for Haematopathology/Society of Hematopathology workshop in Istanbul, Turkey. This session was focused on pediatric-type follicular lymphoma (FL), and its differential diagnosis with the newly recognized entity of IRF4/MUM1+ lymphomas mainly involving Waldeyer's ring. The differential diagnosis between t(14;18) negative FL grade 1/2 and pediatric-type FL in adults was highlighted. The overlapping pathological and clinical features between FL and nodal marginal zone lymphoma (NMZL) in children and young adults were recognized and morphologic and immunophenotypical criteria helpful for the differential diagnosis were presented. Both pediatric-type FL and NMZL are indolent processes that should be distinguished from atypical lymphoid hyperplasia of the tonsils and lymph nodes. The demonstration of a B cell monoclonal population by molecular studies is strongly recommended for the diagnosis. Recognition of these indolent variants to avoid overtreatment was emphasized. Whereas most indolent lymphomas in the pediatric population show characteristic clinical, pathologic, and genetic features that differ from the adult counterpart, other rare indolent lymphoid tumors such as chronic lymphocytic leukemia (CLL) have similar characteristics. In this report, novel findings, areas of special interest, and diagnostic challenges emerging from the cases submitted to the workshop will be discussed.
引用
收藏
页码:141 / 157
页数:17
相关论文
共 50 条
  • [31] Expression and significance of MUM1/IRF4 protein in Hodgkin's and non Hodgkin's lymphoma.
    Graber, MW
    Depowski, PL
    Purdy, S
    Ross, JS
    Nazeer, T
    MODERN PATHOLOGY, 2001, 14 (01) : 165A - 165A
  • [32] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Nagargoje, G
    Trzpuc, T
    Kampalath, B
    Abed, N
    Lorek, J
    Chang, C
    BLOOD, 2001, 98 (11) : 333A - 333A
  • [33] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    LABORATORY INVESTIGATION, 2002, 82 (01) : 267A - 267A
  • [34] A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma
    Holkova, Beata
    Yazbeck, Victor
    Kmieciak, Maciej
    Bose, Prithviraj
    Ma, Shuo
    Kimball, Amy
    Tombes, Mary Beth
    Shrader, Ellen
    Wan, Wen
    Weir-Wiggins, Caryn
    Singh, Amanda
    Hogan, Kevin T.
    Conine, Sarah
    Sankala, Heidi
    Roberts, John D.
    Shea, Thomas C.
    Grant, Steven
    LEUKEMIA & LYMPHOMA, 2017, 58 (06) : 1349 - 1357
  • [35] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    MODERN PATHOLOGY, 2002, 15 (01) : 267A - 267A
  • [36] Expression and significance of MUM1/IRF4 protein in Hodgkin's and non Hodgkin's lymphoma.
    Graber, MW
    Depowski, PL
    Purdy, S
    Ross, JS
    Nazeer, T
    LABORATORY INVESTIGATION, 2001, 81 (01) : 165A - 165A
  • [37] Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 89 BL Patients in Japan
    Satou, Akira
    Asano, Naoko
    Kato, Seiichi
    Elsayed, Ahmed Ali
    Nakamura, Naoya
    Ohshima, Koichi
    Nakamura, Shigeo
    BLOOD, 2015, 126 (23)
  • [38] IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma
    Heo, Mi Hwa
    Park, Ha Young
    Ko, Young Hyeh
    Kim, Won Seog
    Kim, Seok Jin
    JOURNAL OF CANCER, 2017, 8 (06): : 1018 - 1024
  • [39] Composite Biclonal Marginal Zone Lymphoma of Lung and Chronic Lymphocytic Leukemia: Pathologic, Phenotypic, Cytogenetic, and Molecular Study
    Bhagavathi, Sharathkumar
    Micale, Mark A.
    Douglas-Nikitin, Vonda
    Ballouz, Samer
    Neumann, Kurt
    Blenc, Ann Marie
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2011, 19 (03) : 377 - 381
  • [40] Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results
    Holkova, Beata
    Kmieciak, Maciej
    Bose, Prithviraj
    Ma, Shuo
    Kimball, Amy
    Tombes, Mary Beth
    Shrader, Ellen
    Wan, Wen
    Weir-Wiggins, Caryn
    Stoddert, Elizabeth
    Singh, Amanda Garnett
    Dean, April
    Conine, Sarah
    Sankala, Heidi
    Roberts, John D.
    Shea, Thomas C.
    Grant, Steven
    BLOOD, 2014, 124 (21)